Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220816 | SCV001392828 | pathogenic | Saldino-Mainzer syndrome | 2023-07-10 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.007%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 949370). This variant has not been reported in the literature in individuals affected with IFT140-related conditions. This sequence change creates a premature translational stop signal (p.Arg1328Glyfs*12) in the IFT140 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT140 are known to be pathogenic (PMID: 22503633, 23418020, 24009529, 26216056). |
Fulgent Genetics, |
RCV005012630 | SCV005642701 | likely pathogenic | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-06-17 | criteria provided, single submitter | clinical testing |